Effect of regorafenib, anti-PD1, and anti-CD40 agonist in Head and Neck Squamous Cell Carcinoma [HNSCC_model]
RNA-seq (gene expression) · mouse · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 12 samples: 12 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE248153_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1041839 and SRA study SRP472604. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 12 sample titles: 12 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7906479 HNSCC mouse models with treatment of vehicle (#1)
- GSM7906480 HNSCC mouse models with treatment of vehicle (#2)
- GSM7906481 HNSCC mouse models with treatment of vehicle (#3)
- GSM7906482 HNSCC mouse models with treatment of anti-PD1 (#1)
- GSM7906483 HNSCC mouse models with treatment of anti-PD1 (#2)
- GSM7906484 HNSCC mouse models with treatment of anti-PD1 (#3)
- GSM7906485 HNSCC mouse models with treatment of regorafenib (#1)
- GSM7906486 HNSCC mouse models with treatment of regorafenib (#2)
- GSM7906487 HNSCC mouse models with treatment of regorafenib (#3)
- GSM7906488 HNSCC mouse models with treatment of regorafenib + anti-PD1 (#1)
- GSM7906489 HNSCC mouse models with treatment of regorafenib + anti-PD1 (#2)
- GSM7906490 HNSCC mouse models with treatment of regorafenib + anti-PD1 (#3)
- GSE248155 Effect of regorafenib, anti-PD1, and anti-CD40 agonist in Head and Neck Squamous Cell Carcinoma 31 samples shares anti-cd40, anti-pd1, regorafenib, squamous, agonist, head, neck
- GSE248154 Effect of regorafenib, anti-PD1, and anti-CD40 agonist in Head and Neck Squamous Cell Carcinoma [4NQO_model] 19 samples shares anti-cd40, anti-pd1, regorafenib, squamous, agonist, head, neck
- GSE335338 EphA4 Mediates Pro- and Anti- Tumoral Effects Through Upstream Negative Regulation of AKT in Head and Neck Squamous Cell Carcinoma- The effect of EphA4 knockout on RNA expression in HNSCC cell line. 6 samples shares hnscc, squamous, head, neck
- GSE311831 Pertussis toxin-induced lymphocytosis enhances anti-tumor immune environments and improves the anti-PD1 treatment response in a squamous cell carcinoma model. 24 samples shares anti-pd1, squamous
- GSE232557 Effects of anti-CD40 agonist and Cabozantinib on the immune microenvironment of mouse hepatocellular carcinoma 1 samples shares anti-cd40, agonist
- GSE285902 IL-15 complex enhances agonistic anti-CD40 + anti-PDL1 by correcting the T-bet to Tox ratio in CD8+ T cells infiltrating pancreatic ductal adenocarcinoma 9 samples shares anti-cd40, agonist
- GSE301971 Modelling HNSCC in mice with hyperactivated NRF2 pathway 22 samples shares hnscc
- GSE272309 Investigate the role of B cell in response to anti-PD1 + anti-CTLA in hepatocellular carcinoma 21 samples shares anti-pd1
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.